Vivacelle Bio

About:

Vivacelle Bio is a clinical stage biotech company focused on bringing to market a new paradigm in resuscitation fluids.

Website: http://www.vivacellebio.com/

Description:

Vivacelle Bio is a clinical stage biotechnology company focused on creating products that utilize phospholipid nanoparticle technology. The Company's first product, VBI-1, is a circulatory support fluid that is a colloid non-blood volume expander that appears to be two to three times more effective than the standard treatment for hypovolemia and safer in animal studies/experiments. It's second product, VBI-S, is specifically-designed to elevate blood pressure in septic shock patients. This new class of resuscitation fluids is called VIVACELLE.

Total Funding Amount:

$2.45M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2013-01-01

Contact Email:

harven(AT)vivacellebio.com

Founders:

Cuthbert Simpkins, Paul Burton

Number of Employees:

1-10

Last Funding Date:

2018-08-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai